Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Oct;2(10):e408-16.
doi: 10.1016/S2352-3026(15)00151-9. Epub 2015 Sep 17.

Financial toxicity in insured patients with multiple myeloma: a cross-sectional pilot study

Scott F Huntington  1 , Brendan M Weiss  2 , Dan T Vogl  2 , Adam D Cohen  2 , Alfred L Garfall  2 , Patricia A Mangan  2 , Jalpa A Doshi  3 , Edward A Stadtmauer  2
Affiliations

Financial toxicity in insured patients with multiple myeloma: a cross-sectional pilot study

Scott F Huntington et al. Lancet Haematol. 2015 Oct.

Abstract

Background: Financial toxicity is increasingly recognised as adversely affecting the quality of life and medication adherence in patients with cancer in the USA. Patients with multiple myeloma might be particularly vulnerable because of high use of novel treatments and extended treatment duration.

Methods: Between Aug 18, 2014, and Jan 7, 2015, we did a cross-sectional survey of individuals receiving at least 3 months of ongoing treatment for multiple myeloma at a tertiary academic medical centre in the USA. The survey was derived from previous reported studies and included the 11-item COST measure (financial toxicity score range 0-44). A paper survey was offered to eligible patients on arrival for routine follow-up visits, and participants were asked to complete the survey before or after their visit to the clinic. Insurance and treatment data were obtained from patients' electronic health records.

Findings: Of 111 patients approached for the study, 100 individuals completed the survey. 59 (59%) of 100 patients reported that treatment costs were higher than expected, 70 (71%) of 99 had at least minor financial burden, and 36 (36%) of 100 reported applying for financial assistance. Use of savings to pay for myeloma treatment was common (43 [46%] of 94 patients) and 21 (21%) of 98 individuals borrowed money to pay for medications. COST scores were highly correlated with patient-reported use of strategies to cope with myeloma treatment expenses. On multivariable analysis, younger age (correlation coefficient β 0·36, 95% CI 0·15 to 0·56, p=0·00092), non-married status (5·6, 1·5 to 9·6, p=0·0074), longer duration since diagnosis (-4·8, -9·3 to -0·2, p=0·042), and lower household income (US$40 000-79 999: 7·8, 2·7 to 12·9, p=0·0031; ≥$80 000: 11·8, 7·1 to 16·4, p<0·0001) were associated with higher financial burden as measured with the COST score.

Interpretation: Patient-reported financial toxicity and use of coping mechanisms were common in our insured population with multiple myeloma. Additional attention to rising treatment costs and cost sharing is needed to address the increasing evidence of financial toxicity affecting patients with cancer.

Funding: University of Pennsylvania Perelman School of Medicine.

PubMed Disclaimer

Comment in

  • The overlooked COST of multiple myeloma.
    de Souza JA, Muffly L. de Souza JA, et al. Lancet Haematol. 2015 Oct;2(10):e394-5. doi: 10.1016/S2352-3026(15)00192-1. Epub 2015 Sep 17. Lancet Haematol. 2015. PMID: 26686034 No abstract available.

Publication types